Description: ShanXi C&Y Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China, the United States, Hong Kong, and internationally. It offers products for pregnant women and babies; urinary system products; anti-infection products; traditional Chinese medicines; and dermatology products, as well as tea bags. The company was formerly known as Shanxi C&Y Pharmaceutical Co., Ltd. and changed its name to Shanxi C&Y Pharmaceutical Group Co., Ltd. in September 2014. Shanxi C&Y Pharmaceutical Group Co., LTD. was founded in 2005 and is headquartered in Shanghai, China.
Home Page: www.cy-pharm.com
No. 53, Hubin Street
Datong,
037010
China
Phone:
86 35 2611 6426
Officers
| Name | Title |
|---|---|
| Mr. Qun Zhao | Pres & Director |
| Mr. Yanjie He | Financial Director |
| Mr. Ying Min Yu | Chief Engineer |
| Mr. Junxian Yu | Sec., VP & Non-Independent Director |
| Ms. Qing Wang | Chief Financial Officer |
| Mr. Shi Song Guan | VP |
Exchange: SHE
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.7448 |
| Price-to-Sales TTM: | 2.4168 |
| IPO Date: | 2011-08-19 |
| Fiscal Year End: | December |
| Full Time Employees: | 1191 |